Trending News
News
News
Charles River and CHDI Foundation Extend Huntington’s Disease Collaboration
CHDI extends its ongoing collaboration for an additional five years through to 2019.
News
ICON Selected by the FDA to Develop New PRO Measure for HABP Trials
New PRO measure being developed in conjunction with the FNIH Biomarkers Consortium.
News
Advent International Sign Agreement with Avista Capital Partners
Agreement to acquire Kremers Urban Pharmaceuticals from UCB.
News
Almac Announces Launch of CLIA Validated Next Generation Sequencing Assay
P53 considered important biomarker for cancer drug discovery.
News
QIAGEN Signs Ninth Master Collaboration Agreement for Companion Diagnostics
Master collaboration agreement is a framework for developing and commercializing QIAGEN companion diagnostics, paired with new or existing products.
News
UC Davis investigational medication used to resolve life-threatening seizures in children
In its first clinical application in pediatric patients, an investigational medication developed and manufactured at UC Davis has been found to effectively treat children with life-threatening and difficult-to-control epileptic seizures without side effects, according to a research report by scientists at UC Davis and Northwestern University.
News
Rodent study identifies a pathway that starts with glutamate and ends with activation of dopamine reward system
Details of the role of glutamate, the brain's excitatory chemical, in a drug reward pathway have been identified for the first time.
News
Scripps Florida Scientists Unveil New Targets and Test to Develop Treatments for Memory Disorders
In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a number of new therapeutic targets for memory disorders and have developed a new screening test to uncover compounds that may one day work against those disorders.
News
Bilingual brains better equipped to process information
Forget Sudoku: Speaking multiple languages routinely exercises the brain
Speaking more than one language is good for the brain, according to new research that indicates bilingual speakers process information more efficiently and more easily than those who know a single language.
News
Researchers discover common chemotherapeutic agent reduces resistance to virus therapy in brain tumor patients
Moffitt Cancer Center researchers, in conjunction with colleagues at University of Calgary, have found that the common chemotherapeutic agent cyclophosphamide can help improve the success of oncolytic virus therapy in patients with malignant gliomas, a common type of brain tumor.
Advertisement